Christopher D. Maggiore - Jul 28, 2022 Form 4/A - Amendment Insider Report for Zivo Bioscience, Inc. (ZIVO)

Role: Director, 10%+ Owner
Signature: /s/ Christopher D. Maggiore
Stock symbol: ZIVO
Transactions as of: Jul 28, 2022
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 12/8/2022, 03:17 PM
Date Of Original Report: Aug 1, 2022
Previous filing: Feb 16, 2022
Next filing: Aug 1, 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZIVO	Nonstatutory Stock Option to Purchase Common Stock	Award	$0	+15.8K		$0.00	15.8K	Jul 28, 2022	Common stock	15.8K	$3.61	Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This amendment is being filed solely to correct the date of the transaction reported to July 28, 2022.
F2	The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2023 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date.